Optimal management of muscle-invasive bladder cancer - a review
- PMID: 26380230
- PMCID: PMC4567228
- DOI: 10.2147/RRU.S73566
Optimal management of muscle-invasive bladder cancer - a review
Abstract
Muscle-invasive bladder cancer is a complex disease requiring aggressive management. Patients are often older with comorbid conditions that impact treatment options. This review describes the available therapies for invasive urothelial carcinoma, including chemotherapy, radical extirpative surgery, and bladder-preserving strategies.
Keywords: bladder cancer; neoadjuvant chemotherapy; radical cystectomy; urothelial carcinoma.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
-
- Amin MB, McKenney JK, Paner GP, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: pathology. Eur Urol. 2013;63:16–35. - PubMed
-
- Chamie K, Litwin MS. Quality of bladder cancer care in the USA. Expert Rev Pharmacoecon Outcomes Res. 2011;11:619–621. - PubMed
-
- National Comprehensive Cancer Network NCCN Guidelines Version 1.2015. 2015. [Accessed April 30, 2015]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/bladder.pdf.
-
- Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
